Shopping Cart
- Remove All
- Your shopping cart is currently empty
Davoceticept (ALPN-202; CD80 vIgD-Fc), a monoclonal antibody that targets CTLA-4, consists of the (1-107) fragment of CD80 fused to the IGHG1 Fc domain via a peptidyl linker and is typically produced in CHO (Chinese Hamster Ovary) cells [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | Davoceticept (ALPN-202; CD80 vIgD-Fc), a monoclonal antibody that targets CTLA-4, consists of the (1-107) fragment of CD80 fused to the IGHG1 Fc domain via a peptidyl linker and is typically produced in CHO (Chinese Hamster Ovary) cells [1]. |
Alias | CD80 vIgD-Fc, ALPN-202 |
Cas No. | 2307144-64-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.